Literature DB >> 1722773

Specificity of the immune response to the group B polysaccharide of Neisseria meningitidis.

M R Lifely1, J Esdaile.   

Abstract

A panel of monoclonal antibodies (mAb) and polyclonal sera of murine, human and equine origin, of IgM isotype and with specificity for Neisseria meningitidis group B polysaccharide, an alpha(2----8)-linked homopolymer of sialic acid, were examined for their antigenic and biological specificities. The nature of the antigenic determinants on B polysaccharide was investigated using a series of N-acyl derivatives of B polysaccharide, two sialic acid polymers containing alpha(2----9)-linkages and a series of polynucleotides. The panel of antibodies recognized an array of unrelated antigenic determinants on the B polysaccharide, despite its structural simplicity, and all but one were highly effective in an in vitro bactericidal assay and/or in an in vivo murine passive protection model. There was no evidence that B polysaccharide induced antibody capable of blocking biological activity (blocking antibody).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722773      PMCID: PMC1384645     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.

Authors:  H J Jennings; R Roy; A Gamian
Journal:  J Immunol       Date:  1986-09-01       Impact factor: 5.422

2.  Immunohistochemical localization of polysialic acid in tissue sections: differential binding to polynucleotides and DNA of a murine IgG and a human IgM monoclonal antibody.

Authors:  M Husmann; J Roth; E A Kabat; C Weisgerber; M Frosch; D Bitter-Suermann
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

3.  Interaction of meningococcal group B monoclonal antibody and its Fab fragment with alpha 2-8-linked sialic acid polymers: requirement of a long oligosaccharide segment for binding.

Authors:  J Häyrinen; D Bitter-Suermann; J Finne
Journal:  Mol Immunol       Date:  1989-06       Impact factor: 4.407

4.  Conformational and dynamic differences between N. meningitidis serogroup B and C polysaccharides, using n.m.r. spectroscopy and molecular mechanics calculations.

Authors:  J C Lindon; J G Vinter; M R Lifely; C Moreno
Journal:  Carbohydr Res       Date:  1984-10-01       Impact factor: 2.104

5.  Immunological properties of monoclonal antibodies specific for meningococcal polysaccharides: the protective capacity of IgM antibodies specific for polysaccharide group B.

Authors:  C Moreno; J Hewitt; K Hastings; D Brown
Journal:  J Gen Microbiol       Date:  1983-08

6.  Rate, mechanism, and immunochemical studies of lactonisation in serogroup B and C polysaccharides of Neisseria meningitidis.

Authors:  M R Lifely; A S Gilbert; C Moreno
Journal:  Carbohydr Res       Date:  1984-12-01       Impact factor: 2.104

7.  Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

8.  Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.

Authors:  C Moreno; M R Lifely; J Esdaile
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

9.  Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum.

Authors:  P A Rice; H E Vayo; M R Tam; M S Blake
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  The epitope associated with the binding of the capsular polysaccharide of the group B meningococcus and of Escherichia coli K1 to a human monoclonal macroglobulin, IgMNOV.

Authors:  E A Kabat; J Liao; E F Osserman; A Gamian; F Michon; H J Jennings
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  4 in total

1.  Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.

Authors:  W D Zollinger; E E Moran; S J Devi; C E Frasch
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.

Authors:  John B Robbins; Rachel Schneerson; Guilin Xie; Lars Å Hanson; Lars Åke-Hanson; Mark A Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

3.  The conformational properties of methyl alpha-(2,8)-di/trisialosides and their N-acyl analogues: implications for anti-Neisseria meningitidis B vaccine design.

Authors:  Austin B Yongye; Jorge Gonzalez-Outeiriño; John Glushka; Verena Schultheis; Robert J Woods
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

Review 4.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.